NEUVOGEN Trademark

Trademark Overview

On Wednesday, March 25, 2020, a trademark application was filed for NEUVOGEN with the United States Patent and Trademark Office. The USPTO has given the NEUVOGEN trademark a serial number of 88847538. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, December 11, 2024. This trademark is owned by ImmunoActiva, Inc.. The NEUVOGEN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Vaccines

Research and development of vaccines and medicines
neuvogen

General Information

Serial Number88847538
Word MarkNEUVOGEN
Filing DateWednesday, March 25, 2020
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, December 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2024

Trademark Statements

Goods and ServicesVaccines
Goods and ServicesResearch and development of vaccines and medicines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 31, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 31, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNEUVOGEN, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121
Party NameImmunoActiva, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Saturday, March 28, 2020NEW APPLICATION ENTERED
Tuesday, March 31, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 16, 2020ASSIGNED TO EXAMINER
Tuesday, June 16, 2020NON-FINAL ACTION WRITTEN
Tuesday, June 16, 2020NON-FINAL ACTION E-MAILED
Tuesday, June 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 1, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, November 23, 2020SUSPENSION LETTER WRITTEN
Monday, November 23, 2020LETTER OF SUSPENSION E-MAILED
Monday, November 23, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, May 23, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, November 24, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, December 20, 2021NON-FINAL ACTION WRITTEN
Monday, December 20, 2021NON-FINAL ACTION E-MAILED
Monday, December 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 16, 2022SUSPENSION LETTER WRITTEN
Thursday, June 16, 2022LETTER OF SUSPENSION E-MAILED
Thursday, June 16, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, December 21, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, July 13, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, July 18, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, January 27, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, September 5, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, November 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 14, 2024ASSIGNED TO LIE
Friday, December 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Related Keywords

neuvogen vaccines medicines research development